申请人:BASF Aktiengesellschaft
公开号:US05260330A1
公开(公告)日:1993-11-09
Substituted anilides of the formula I ##STR1## (where R.sup.1 is C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.4 -haloalkyl, C.sub.1 -C.sub.4 -alkoxy, halogen, cyano, nitro, C.sub.2 -C.sub.4 -alkenyl, C.sub.2 -C.sub.4 -alkynyl; X is methylene, ethylene, vinylene; R.sup.2 and R.sup.3 are each C.sub.1 -C.sub.4 -alkyl, C.sub.3 -C.sub.6 -cycloalkyl or together are tetra- or pentamethylene; R.sup.4 is C.sub.1 -C.sub.4 -alkyl, methoxy; n is 2, 3 or 4), and the physiologically tolerated acid addition salts thereof, the pharmaceutical use thereof, drugs produced therefrom and the use thereof for treating cardiac arrhythmias and/or for lowering the heart rate, are described.
描述了公式I的取代苯胺酰胺(其中R^1是C1-C4-烷基,C1-C4-卤代烷基,C1-C4-烷氧基,卤素,氰基,硝基,C2-C4-烯基,C2-C4-炔基;X是亚甲基,乙烯基,乙烯基;R^2和R^3分别是C1-C4-烷基,C3-C6-环烷基,或者一起是四甲基或五甲基亚甲基;R^4是C1-C4-烷基,甲氧基;n为2、3或4),以及其生理耐受的酸盐,其药用途,由此制得的药物以及用于治疗心律失常和/或降低心率的用途。